- Posts by Alan Silber
Of CounselAlan Silber has litigated cases in numerous federal and state courts across the United States. He has also tried a variety of major white-collar cases involving RICO, bank, securities, telemarketing, health care, and wire and mail ...
In an important victory for the rights of medical marijuana users, on April 13, 2021, the New Jersey Supreme Court affirmed an Appellate Division ruling, holding that a workers’ compensation judge may order employers in the State of New Jersey to reimburse injured employees for the cost of medical marijuana. Pashman Stein attorneys Alan Silber and Dillon J. McGuire represented several organizations as amici curiae before the New Jersey Supreme Court: (1) National Organization for the Reform of Marijuana Laws (NORML); (2) Garden State–NORML (GS-NORML); (3) Coalition For ...
Alan Silber a member of Pashman Stein Walder Hayden's Cannabis Law Group was extensively quoted in the Asbury Park Press article, "NJ Marijuana Legalization: Lawyers Say Weed is Good for You."
“So, you have a substance which you’re saying is illegal, which is identical to a substance that is made in the human body to keep us healthy,’’ Silber said. “What’s wrong with that picture?’’
He added, “Medical benefits from the use of marijuana not known in 1971, …and impediments to its lawful use as a result of its Schedule 1 classification, are abundant and glaringly ...
1524263834
Registration For The Twelfth National Clinical Conference On Cannabis Therapeutics
Pashman Stein Walder Hayden Attorneys Alan Silber, CJ Griffin and Ronny Jo Siegal are set to present on in Jersey City on May 10th at The Twelfth National Clinical Conference on Cannabis Therapeutics hosted by Patients Out of Time.
The Pre-Conference Policy Workshop: Medical Cannabis in the States of Confusion is scheduled for Thursday, May 10, immediately prior to the conference. Patients Out of Time will offer a policy seminar featuring experts in law, science, and policies. This ...
De-Scheduling could have significant impact on how marijuana is regulated in New Jersey
Pashman Stein Walder Hayden filed a Brief De-Scheduling Marijuana today in support of the de-scheduling marijuana, and is in direct response to New Jersey’s Division of Consumer Affairs solicitation for public comment on how marijuana is classified under state law and whether any change in its classification status is warranted.
To reevaluate whether the currently accepted uses for medical marijuana warrant a change in its classification as a “Schedule I” drug in New Jersey, a ...
